Charles DeCarli from UC Davis Health System: New Tests Provide Insight Into Alzheimer's Diagnosis

Video

It was not very long ago that the only way to accurately diagnose Alzheimer's disease was after a patient had died. Since that time, a lot has been learned about the disease and other forms of dementia.

It was not very long ago that the only way to accurately diagnose Alzheimer's disease was after a patient had died. Since that time, a lot has been learned about the disease and other forms of dementia.

Charles S. DeCarli, MD, from UC Davis Health System, said it is important to differentiate between the different forms of dementia to determine the proper diagnosis. As more is learned about amyloids and tau protiens, DeCarli said doctors will be able to have a clearer picture of the patients most at risk of developing Alzheimer's disease.

Related Videos
Elizabeth Cerceo, MD | Credit: ACP
Insight on the Promising 52-Week KarXT Data with Rishi Kakar, MD
Sunny Rai, PhD: “I” Language Markers Do Not Detect Depression in Black Individuals
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
© 2024 MJH Life Sciences

All rights reserved.